LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 171 filers reported holding LEGEND BIOTECH CORP in Q4 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,374,865 | +41.1% | 407,546 | +45.0% | 0.45% | +36.2% |
| Q2 2023 | $19,404,402 | -32.8% | 281,101 | -53.0% | 0.33% | -37.2% |
| Q1 2023 | $28,856,198 | +106.4% | 598,428 | +113.7% | 0.52% | +91.9% |
| Q4 2022 | $13,982,093 | -61.6% | 280,090 | -68.6% | 0.27% | -59.6% |
| Q3 2022 | $36,373,000 | +45.7% | 891,512 | +96.4% | 0.68% | +35.5% |
| Q2 2022 | $24,970,000 | +486.7% | 454,007 | +354.0% | 0.50% | +531.6% |
| Q2 2020 | $4,256,000 | – | 100,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 814,586 | $56,230,872 | 17.46% |
| Paradigm Biocapital Advisors LP | 1,805,717 | $124,648,645 | 9.63% |
| HHLR ADVISORS, LTD. | 6,436,533 | $444,313,873 | 9.46% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,123,692 | $77,568,459 | 9.09% |
| RA Capital Management | 6,264,707 | $432,452,724 | 8.16% |
| Tri Locum Partners LP | 116,768 | $8,060,495 | 3.00% |
| Nicholas Investment Partners, LP | 593,167 | $40,946,318 | 2.80% |
| E Fund Management (Hong Kong) Co., Ltd. | 51,679 | $3,567 | 2.66% |
| Avidity Partners Management LP | 798,900 | $55,148,067 | 1.93% |
| Boxer Capital, LLC | 600,000 | $41,418 | 1.92% |